Lucid Diagnostics Inc. (LUCD) stock
Close on Nov 17, 2026Market cap $81.09MP/E –Yield –
Earnings
Lucid Diagnostics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Lucid Diagnostics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 25, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 12, 2026before the open | $1.20M | 0.0% | -$0.03 | -$0.06 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 13, 2026before the open | $1.50M | +25.0% | -$0.08 | -$0.06 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 14, 2026before the open | $1.26M | +57.0% | -$0.17 | -$0.07 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 26, 2026before the open | $1.50M | +25.0% | -$0.12 | -$0.10 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 12, 2025before the open | $1.20M | 0.0% | -$0.10 | -$0.10 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 13, 2025before the open | $1.20M | +20.0% | -$0.08 | -$0.10 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 14, 2025before the open | $800.00K | -20.0% | -$0.52 | -$0.16 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 25, 2025before the open | $1.20M | – | -$0.20 | -$0.19 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 13, 2024before the open | $1.20M | +53.3% | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 12, 2024before the open | $1.00M | – | -$0.23 | -$0.20 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 14, 2024before the open | $1.00M | – | -$0.40 | -$0.21 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 14, 2023after the close | $783.00K | +683.0% | -$0.34 | -$0.22 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 14, 2023after the close | $100.00K | -66.7% | -$0.47 | -$0.33 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 14, 2022after the close | $100.00K | – | -$0.39 | -$0.28 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 15, 2022after the close | – | – | -$0.41 | -$0.28 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 12, 2022after the close | $200.00K | – | -$0.35 | -$0.23 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 29, 2022after the close | $300.00K | – | -$0.20 | -$0.15 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
No open guidance: every period Lucid Diagnostics guided for has been reported
Guidance history
Every forecast Lucid Diagnostics put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Mar 14, 2023 | commercial EsoGuard tests | Q1 FY2023 | 1600 | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Lucid Diagnostics filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
- Update
- Update
- Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial ResultsResults
- Results
- Update
- Update
- Update
- Update
- Results
- Results
- Update
See a number that looks wrong?